What is NDC 51662-1412?

51662-1412 is the product NDC for Lidocaine Hci And Epinephrine With Epinephrine, Epinephrine bitartrate .005 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Lidocaine Hci And Epinephrine With Epinephrine.

What is the active ingredient?

Epinephrine bitartrate, Lidocaine hydrochloride anhydrous.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lidocaine Hci And Epinephrine With Epinephrine?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 51662-1412

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1412Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1412Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1412-1	5166214120151662141201	10 mL in 1 VIAL, SINGLE-DOSE (51662-1412-1)Marketed from Oct 14, 2019
51662-1412-3	5166214120351662141203	25 POUCH in 1 BOX (51662-1412-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1412-2) / 10 mL in 1 VIAL, SINGLE-DOSEMarketed from Mar 16, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lidocaine Hci And Epinephrine With Epinephrine
Generic name (nonproprietary): lidocaine hci and epinephrine with epinephrine
Active ingredients: Epinephrine bitartrate — .005 mg/mLLidocaine hydrochloride anhydrous — 20 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration, Intracaudal, Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 006488
Marketing start: Oct 14, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Amides (Chemical structure)Catecholamines (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1412_0f906587-01ab-1870-e063-6294a90a3393SPL ID 0f906587-01ab-1870-e063-6294a90a3393SPL set ID 94e9f2db-af29-032e-e053-2995a90a7f7bRxCUI 1868028UNII 30Q7KI53AK, EC2CNF7XFPUPC 0363323489014
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662141201 followed by a unit qualifier and the quantity

Package 51662-1412-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1412

What is NDC 51662-1412?: 51662-1412 is the product NDC for Lidocaine Hci And Epinephrine With Epinephrine, Epinephrine bitartrate .005 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lidocaine Hci And Epinephrine With Epinephrine.
What is the active ingredient?: Epinephrine bitartrate, Lidocaine hydrochloride anhydrous.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lidocaine Hci And Epinephrine With Epinephrine?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 006488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 006488
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hci And Epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1505
Lidocaine Hci And Epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1506
XYLOCAIN (LIDOCAINE HCl )xylocaine (lidocaine hcl )	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1587
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Henry Schein, Inc.	0404-9972
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9973
Xylocainelidocaine hcl	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9974
Xylocainelidocaine hydrochloride, epinephrine bitartrate injection, solution	Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc	0404-9975
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9976
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9977
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	A-S Medication Solutions	50090-6851
Xylocaine	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1590
Xylocaine	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1591
Xylocaine	Epinephrine bitartrate .01 mg/mL; Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1622
Xylocaine	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1645
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-481
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-482
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-483
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 5 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-484
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-485
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-486

Showing 20 of 39.

Lidocaine Hci And Epinephrine With Epinephrine NDC 51662-1412